Protagenic Therapeutics, Inc. - PTIX Forvard P/S multiplikatori
Peptidlar yetkazib berish uchun sovuq zanjirni optimallashtirish operatsion barqarorlikni ta'minlab, Protagenic Therapeutics (PTIX) uchun Tcap patent himoyasi va FDA talablariga muvofiqligi uchun asos yaratadi. GURU.Markets platformasidagi forward P/S koeffitsiyenti tendentsiyasi ushbu barqarorlikni aks ettiradi, bunda joriy ko'rsatkichni ifodalaydi. Umumiy manzarani esa nojo'ya ta'sirlarsiz miyaning tabiiy muvozanatini tiklaydigan innovatsion antidepressantlarning ishlab chiqilishi to'ldiradi.
protagenic.com (PTIX) kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- emitentning bozor qiymati haqida ma'lumotlar:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Protagenic Therapeutics|PTIX - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Protagenic Therapeutics, Inc.|PTIX - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Protagenic Therapeutics, Inc.|PTIX - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Protagenic Therapeutics|Tezkor likvidlik koeffitsiyenti protagenic.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
PTIX - Sof foyda|Kutilayotgan foyda Protagenic Therapeutics|PTIX - Kapitalizatsiyaning sof foydaga nisbati|Forvard P/E multiplikatori Protagenic Therapeutics, Inc.|PTIX - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Protagenic Therapeutics, Inc.|PTIX - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Protagenic Therapeutics|PTIX - So'nggi to'rtta chorak uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi protagenic.com|PTIX - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Protagenic Therapeutics
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:Protagenic PTIX
Ishlab chiqarish va klinik sinovlarni autsorsing qilish orqali Protagenic Therapeutics (PTIX) kapital xarajatlarini minimallashtirib, buning o'rniga intellektual kapitalga e'tibor qaratmoqda. Kutilayotgan P/S ko'rsatkichi bozor kapitalizatsiyasiga nisbatan kelajakdagi daromad oqimlarining bozor qiymatini aks ettiradi, bu esa investorlarga ilmiy ishlanmalarning tijoriy muvaffaqiyatga aylanish tezligini baholash va ushbu tendentsiyaga asoslanib aktivlarning haddan tashqari qimmat baholanganligi belgilarini aniqlash imkonini beradi.
Raqobatchilar tahlili
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Regencell - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Axsome Corp AXSM|ACAD: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori xenon-pharma.com|Forvard narx/daromad multiplikatori VKTX|SUPN: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CPRX (Catalyst Pharmaceuticals Inc)|Narxning kutilayotgan daromadga nisbati DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Sotuvga nisbatan forvard narx BHVN|Amylyx Pharmaceuticals, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Trevi Therapeutics Inc|Praxis Medicines (PRAX) - Narxning prognoz qilingan daromadga nisbati|Anavex Life Sciences Corp - Sotuvga nisbatan forvard narx|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Prothena Corporation|Narxning prognoz qilingan daromadga nisbati Alector, Inc. (ALEC)|ANNX: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori OMER (Omeros)|Neurogene Therapeutics (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ACIU: Forvard narx/daromad multiplikatori|VYGR - Forvard P/S multiplikatori|NMRA (Neumora Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|SCLX: Narxning kutilayotgan daromadga nisbati|TVGN (Tevogen Bio Holdings, Inc.) - Forvard P/S multiplikatori|Alpha Cognition Corp (ACOG) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori CGTX|Forvard narx/daromad multiplikatori inhibikase.com IKT|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Assertio Holdings (ASRT)|COYA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati VTGN|OVID (ovidrx.com) - Forvard narx/daromad multiplikatori|ABOS: Narxning kutilayotgan daromadga nisbati|CRVO (CervoMed) - Forvard P/S multiplikatori|Alterity Therapeutics Ltd (ATHE) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori CLNN (Clene Inc.)|pepgen.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|RLMD: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Annovis Bio - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience Inc) - Forvard narx/daromad multiplikatori|Klotho Neurosciences (KLTO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati NeuroSense Therapeutics Ltd|RVPH: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati MetaVia Inc (MTVA)|NRXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Helius Medical Technologies HSDT|PASG (Passage Bio Inc.) - Kelajakdagi narxning daromadga nisbati|NEUP - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx NERV (minervaneurosciences.com)|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Addex Therapeutics Ltd. (ADXN)|Forvard narx/daromad multiplikatori ALZN|CYCN (Cyclerion) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Forvard P/S multiplikatori cortigent.com (CRGT)|Forvard P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|Prognoz narxning daromadga nisbati Brainstorm Cell Therapeutics Inc.|Cara Therapeutics, Inc - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Chromocell|eliemtx.com (ELYM) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ITCI|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Marinus Pharmaceuticals Inc (MRNS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori NKGN|Forvard narx/daromad multiplikatori NeuroBo Pharma NRBO|Sage Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SNPX|TRVN: Forvard narx/daromad multiplikatori|Vigil Neuroscience - Narxning kutilayotgan daromadga nisbati|WENA: Forvard P/S multiplikatori|Cerevel Corp - Sotuvga nisbatan forvard narx
